GLP-1 medications produce significant weight loss in clinical trials, with average results ranging from 15 to 22 percent of body weight depending on the medication and dose
GLP-1 receptor agonists slow gastric emptying, meaning food remains in the stomach longer before moving into the small intestine
The observed 18.6- and 20.9 pmol/l rise in circulating plasma PYY levels at 30 and 60 min is in line with previous studies which administered a mixture of SCFAs
Most users see brighter tone between weeks 8 and 12
For a deeper look at the full range of benefits beyond skin brightening, including detoxification, immune support and energy, read our detailed guide: 10 Transformative Benefits of a Glutathione and Vitamin C IV Drip
An active-comparator new-user cohort design [31, 32] compares initiators of different active treatments by emulating an active-controlled randomized trial